(TheNewswire)

Vancouver, BC TheNewswire – February 16 th 2021 Quizam Media Corporation (“the Company”) (CSE:QQ) (CNSX:QQ.CN) (OTC: QQQFF) is pleased to announce that its subsidiary, Quantum 1 Cannabis (“Quantum”), one of Canada’s fastest growing and leading recreational cannabis retailers, has signed a Memorandum of Understanding (“MOU”) to acquire an approved, municipal cannabis retail location in one of Vancouver’s most diverse neighborhoods at 41 st and Cambie Street in Vancouver, BC.


“This flagship location expands our footprint in the Lower Mainland and has exceptional potential for growth. With over a billion dollars of development being spent at Oakridge Centre, density will significantly increase in what is already a high traffic area,” stated CEO Russ Rossi.  “Our dedicated team of experts is excited to serve our growing base of customers with a service and retail experience unlike anything seen in BC before.”

Under the terms of the MOU agreement, Quantum has 20 days to complete its due diligence, finalize terms in a definitive agreement, and ensure the smooth transfer of all licenses and permits.

The new 2,400 square foot location will feature a full service, recreational cannabis retail experience featuring an upscale, contemporary design and a staff of highly trained cannabis consultants.  This prime location has a long-term lease in place and a development permit issued from the City of Vancouver.

In the past twelve months, Quantum 1 has opened stores in North Vancouver, Vernon, Grand Forks, Keremeos and Creston.

About Quantum1 Cannabis Corp.

Growing Together. Quantum 1 was born from our desire to cultivate great energy and interactions with our communities.   Our retail stores bring together good vibes and good people, aiming to forge connections to cannabis in meaningful ways.  We consider every product, every service offering in our stores as forms of energy that can heighten our own energies and in turn our collective world.  That’s why everything we serve is set to the highest standards.

Quantum1 ( www.quantum1cannabis.com ) is a wholly owned subsidiary of Quizam Media a publically traded company on the CSE: QQ and US: QQQFF

CSE Trading Symbol: QQ

Telephone: (604) 683-0020

Email: ir@quizammedia.com

Website: www.quantum1cannabis.com

Facsimile: (604) 683-0045

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and nature of potential acquisitions, joint ventures, partnerships, business dealings and financings, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. Readers are cautioned not to place undue reliance on the forward-looking statements made in this Press Release.

Copyright (c) 2021 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less

New findings suggest the COVID-19 pandemic, combined with expanded state legalization, has attracted new consumers to the category and accelerated cannabis acceptance and adoption.

  • YouGov study indicates the number of current cannabis consumers has increased 56% within just two years compared to the 16% of Americans who reported current consumption in 2018.
  • 23% of current consumers say they tried cannabis for the first time within the past year.
  • More than half of cannabis consumers say they will purchase or try a new product or format this 420, indicating that the holiday is becoming increasingly focused on exploration and trial.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, released the results of a survey today showing one in four Americans currently consume cannabis, reporting they’ve tried some form of cannabis within the past twelve months. That’s a significant increase since 2018* when just 16% of U.S. adults reported current consumption, representing a 56% increase in just two years. What’s more, 23% of current cannabis consumers say they tried cannabis for the first time over the past year, suggesting the COVID-19 pandemic, combined with expanded state legalization, has rapidly accelerated cannabis acceptance and adoption in America.

Keep reading... Show less

Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase price represents a mid-single digit multiple of KCR’s expected 2021 EBITDA

Keep reading... Show less